Cargando…
A first case of successful using of ibrutinib in treating paraneoplastic pemphigus related bronchiolitis obliterans concurrent with CLL
Paraneoplastic pemphigus (PNP) is a rare life-threatening disease which always associated with an underlying neoplasm. Tumor-related PNP most commonly precedes the detection of a hematological malignancy, with some cases seen during disease remission following cytotoxic drug therapy or radiotherapy....
Autores principales: | Chen, Can, Xu, Ying, Yu, Jingdi, Qian, Shenxian, Xie, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056216/ https://www.ncbi.nlm.nih.gov/pubmed/37007770 http://dx.doi.org/10.3389/fmed.2023.1132535 |
Ejemplares similares
-
Unicentric castleman disease complicated by paraneoplastic bronchiolitis obliterans and pemphigus
por: Raza, Hassan A., et al.
Publicado: (2018) -
Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease
por: Chen, Wenhui, et al.
Publicado: (2022) -
Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab
por: Ito, Yuta, et al.
Publicado: (2018) -
Bronchiolitis obliterans
por: King, Talmadge E.
Publicado: (1989) -
Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children
por: Huang, Fei, et al.
Publicado: (2021)